Theravance Biopharma, Inc.
NASDAQ:TBPHBiotechnology
Healthcare
$17.03 -0.42%
-$0.07 today
- Market cap
- $882.64M
- Beta
- 0.18
- P/E (TTM)
- 7.4
- EPS (TTM)
- $2.23
52W Low $10.44High $21.03
Volume 10.02M
Average 0.43M
Price history
Theravance Biopharma, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-4.86%
Period high
$20.74
Period low
$13.57
Latest
$17.03
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13D/A | Sep 25, 2026 | Sep 25, 2026 | |
| S-8 POS | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| S-8 POS | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| S-8 POS | Sep 24, 2026 | Sep 24, 2026 | |
| S-8 POS | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| S-8 POS | Sep 24, 2026 | Sep 24, 2026 | |
| S-8 POS | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| S-8 POS | Sep 24, 2026 | Sep 24, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 |
Competitors
Who does Theravance Biopharma, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about TBPH's filings, answered from its disclosures.
What is the latest TBPH filing?
The latest filing shown is SC 13D/A dated Sep 25, 2026.
How many recent filings does TBPH have?
Intrinsic Alpha currently shows 20 recent filings for TBPH.
Continue the stock analysis
Jump to another research area for this company.